tiprankstipranks
Trending News
More News >
Purple Biotech (PPBT)
NASDAQ:PPBT
US Market

Purple Biotech (PPBT) Financial Statements

Compare
1,150 Followers

Purple Biotech Financial Overview

Purple Biotech's market cap is currently $5.98M. The company's EPS TTM is $-19.85; its P/E ratio is ―; Purple Biotech is scheduled to report earnings on February 11, 2026, and the estimated EPS forecast is $-0.38. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 195.80K$ 0.00$ 0.00
Gross Profit$ 0.00$ -186.00K$ -196.00$ -120.00$ -55.00
Operating Income$ -27.68M$ -11.01M$ -22.27M$ -22.60M$ -17.93M
EBITDA$ -27.68M$ -7.05M$ -19.88M$ -21.49M$ -17.52M
Net Income$ -26.81M$ -7.24M$ -19.88K$ -21.67M$ -18.38M
Balance Sheet
Cash & Short-Term Investments$ 9.57M$ 8.52M$ 15.41M$ 32.11M$ 47.20M
Total Assets$ 17.57M$ 37.04M$ 44.30M$ 54.62M$ 70.20M
Total Debt$ 244.00K$ 183.00K$ 351.00K$ 515.00K$ 749.00K
Net Debt$ -8.47M$ -7.22M$ -14.14M$ -14.52M$ -10.14M
Total Liabilities$ 7.91M$ 4.13M$ 10.01M$ 7.52M$ 5.09M
Stockholders' Equity$ 9.71M$ 32.86M$ 34.21M$ 46.91M$ 64.83M
Cash Flow
Free Cash Flow$ -5.54M$ -14.37M$ -19.93M$ -16.96M$ -15.19M
Operating Cash Flow$ -5.54M$ -14.37M$ -19.93M$ -16.73M$ -15.07M
Investing Cash Flow$ 449.54K$ 509.00K$ 13.88M$ 19.91M$ 13.41M
Financing Cash Flow$ 6.41M$ 6.77M$ 5.45M$ 1.11M$ 1.51M
Currency in USD

Purple Biotech Earnings and Revenue History

Purple Biotech Debt to Assets

Purple Biotech Cash Flow

Purple Biotech Forecast EPS vs Actual EPS